Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Zintellect
- Harvard University
- Center for Drug Evaluation and Research (CDER)
- University of Michigan
- Nature Careers
- City of Hope
- University of Texas at Austin
- Indiana University
- University of Maryland, Baltimore
- Carnegie Mellon University
- Emory University
- Wayne State University
- Center for Devices and Radiological Health (CDRH)
- Central Michigan University
- Cornell University
- The University of Alabama
- University of North Carolina at Charlotte
- Villanova University
- Auburn University
- Missouri University of Science and Technology
- Montana State University
- Office of Women's Health Grant Program (OWH GP)
- Princeton University
- The California State University
- University of North Carolina at Greensboro
- Yeshiva University
- Amgen
- Brandeis University
- Cedars Sinai Medical Center
- Duke University
- Lawrence Berkeley National Laboratory
- The Ohio State University
- The University of Iowa
- Tulane University
- University of Kansas Medical Center
- University of Tennessee Medical Center at Knoxville
- Vanderbilt University
- American University
- Barnard College
- Belmont University
- Bucknell University
- Case Western Reserve University
- Center for Biologics Evaluation and Research (CBER)
- Chippewa Valley Technical College
- Cold Spring Harbor Laboratory
- Creighton University
- Drexel University
- George Mason University
- MASSACHUSETTS GENERAL HOSPITAL
- Marquette University
- National Renewable Energy Laboratory NREL
- SUNY
- Saint Louis University
- The Chinese University of Hong Kong
- University of California
- University of Denver
- University of Massachusetts Dartmouth
- University of Miami
- University of Nebraska Medical Center
- University of Texas at Dallas
- University of Vermont Medical Center
- University of Virginia
- Utah Valley University
- Virginia Tech
- 54 more »
- « less
-
Field
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 20 hours ago
developing comprehensive databases to systematically evaluate the current landscape of in vitro data utilization in drug development. This research will contribute to the development of innovative
-
enable real world application. Fellows will gain hands-on exposure to translational science, drug discovery, and technology development, with opportunities to contribute to intellectual property
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 20 hours ago
under abbreviated new drug applications (ANDAs) and NDAs. The project will identify and develop in vitro, in vivo, or in silico techniques that may be capable of determining how various complexity factors
-
Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | about 20 hours ago
both the development and regulation of oligonucleotide drugs. Learning Objectives: Under the guidance of the mentor, you will receive instructions on utilizing chromatography, mass spectrometry, and
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 20 hours ago
drugs, including biological therapeutics and generic drugs. This work covers more than just medicines. Research Project: This research project aims to develop quantitative structure-activity relationship
-
-derived specimens. In addition, experimental therapeutics will be developed based on preliminary findings. These discoveries are expected to provide a strong foundation for future clinical translation and
-
; develop new leaders in the study of inequality who can publish at the highest level, reach the widest audience, and impact policy; and deepen teaching expertise on the subject of inequality. The two-year
-
person per laboratory may apply for funding, per funding round, per journal. Deadline Month: March, May, August, and October Description: The Company of Biologists' journals – Development, Journal of Cell
-
Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 21 hours ago
(PROs) represent the only quantitative tool available to assess tolerability of oncologic agents under development, providing unique insights into the patient experience of symptomatic adverse events
-
to a deeply decarbonized and reliable energy system. The Postdoctoral Fellow will work closely with the project directors and collaborators to develop data-driven and economically grounded frameworks